
Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting ...
Introduction Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease mediated by immune dysfunction. Diffuse large B-cell lymphoma (DLBCL) represents one of the most common types of non-Hodgkin lymphoma. However, its occurrence in …